326 related articles for article (PubMed ID: 26234946)
1. Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZ.
Sonamoto R; Kii I; Koike Y; Sumida Y; Kato-Sumida T; Okuno Y; Hosoya T; Hagiwara M
Sci Rep; 2015 Aug; 5():12728. PubMed ID: 26234946
[TBL] [Abstract][Full Text] [Related]
2. Expression and purification of recombinant NRL-Hsp90α and Cdc37-CRL proteins for in vitro Hsp90/Cdc37 inhibitors screening.
He J; Niu X; Hu C; Zhang H; Guo Y; Ge Y; Wang G; Jiang Y
Protein Expr Purif; 2013 Nov; 92(1):119-27. PubMed ID: 24056254
[TBL] [Abstract][Full Text] [Related]
3. Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B.
Papenfuss M; Lützow S; Wilms G; Babendreyer A; Flaßhoff M; Kunick C; Becker W
Sci Rep; 2022 Feb; 12(1):2393. PubMed ID: 35165364
[TBL] [Abstract][Full Text] [Related]
4. Protein quality control of DYRK family protein kinases by the Hsp90-Cdc37 molecular chaperone.
Miyata Y; Nishida E
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119081. PubMed ID: 34147560
[TBL] [Abstract][Full Text] [Related]
5. Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte.
Ota A; Zhang J; Ping P; Han J; Wang Y
Circ Res; 2010 Apr; 106(8):1404-12. PubMed ID: 20299663
[TBL] [Abstract][Full Text] [Related]
6. Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1.
Gaude H; Aznar N; Delay A; Bres A; Buchet-Poyau K; Caillat C; Vigouroux A; Rogon C; Woods A; Vanacker JM; Höhfeld J; Perret C; Meyer P; Billaud M; Forcet C
Oncogene; 2012 Mar; 31(12):1582-91. PubMed ID: 21860411
[TBL] [Abstract][Full Text] [Related]
7. Medium-Throughput Detection of Hsp90/Cdc37 Protein-Protein Interaction Inhibitors Using a Split
Siddiqui FA; Parkkola H; Manoharan GB; Abankwa D
SLAS Discov; 2020 Feb; 25(2):195-206. PubMed ID: 31662027
[TBL] [Abstract][Full Text] [Related]
8. Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoning.
Smith JR; Workman P
Cell Cycle; 2009 Feb; 8(3):362-72. PubMed ID: 19177013
[TBL] [Abstract][Full Text] [Related]
9. Split Renilla luciferase protein fragment-assisted complementation (SRL-PFAC) to characterize Hsp90-Cdc37 complex and identify critical residues in protein/protein interactions.
Jiang Y; Bernard D; Yu Y; Xie Y; Zhang T; Li Y; Burnett JP; Fu X; Wang S; Sun D
J Biol Chem; 2010 Jul; 285(27):21023-36. PubMed ID: 20413594
[TBL] [Abstract][Full Text] [Related]
10. Heat-shock protein 90 and Cdc37 interact with LKB1 and regulate its stability.
Boudeau J; Deak M; Lawlor MA; Morrice NA; Alessi DR
Biochem J; 2003 Mar; 370(Pt 3):849-57. PubMed ID: 12489981
[TBL] [Abstract][Full Text] [Related]
11. Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine.
Xu W; Mollapour M; Prodromou C; Wang S; Scroggins BT; Palchick Z; Beebe K; Siderius M; Lee MJ; Couvillon A; Trepel JB; Miyata Y; Matts R; Neckers L
Mol Cell; 2012 Aug; 47(3):434-43. PubMed ID: 22727666
[TBL] [Abstract][Full Text] [Related]
12. ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system.
Polier S; Samant RS; Clarke PA; Workman P; Prodromou C; Pearl LH
Nat Chem Biol; 2013 May; 9(5):307-12. PubMed ID: 23502424
[TBL] [Abstract][Full Text] [Related]
13. Hsp90·Cdc37 Complexes with Protein Kinases Form Cooperatively with Multiple Distinct Interaction Sites.
Eckl JM; Scherr MJ; Freiburger L; Daake MA; Sattler M; Richter K
J Biol Chem; 2015 Dec; 290(52):30843-54. PubMed ID: 26511315
[TBL] [Abstract][Full Text] [Related]
14. Cdc37 (cell division cycle 37) restricts Hsp90 (heat shock protein 90) motility by interaction with N-terminal and middle domain binding sites.
Eckl JM; Rutz DA; Haslbeck V; Zierer BK; Reinstein J; Richter K
J Biol Chem; 2013 May; 288(22):16032-42. PubMed ID: 23569206
[TBL] [Abstract][Full Text] [Related]
15. Differential Regulation of G1 CDK Complexes by the Hsp90-Cdc37 Chaperone System.
Hallett ST; Pastok MW; Morgan RML; Wittner A; Blundell KLIM; Felletar I; Wedge SR; Prodromou C; Noble MEM; Pearl LH; Endicott JA
Cell Rep; 2017 Oct; 21(5):1386-1398. PubMed ID: 29091774
[TBL] [Abstract][Full Text] [Related]
16. The CDC37-HSP90 chaperone complex co-translationally degrades the nascent kinase-dead mutant of HIPK2.
Müller JP; Klempnauer KH
FEBS Lett; 2021 Jun; 595(11):1559-1568. PubMed ID: 33786814
[TBL] [Abstract][Full Text] [Related]
17. Cdc37 as a Co-chaperone to Hsp90.
Prince TL; Lang BJ; Okusha Y; Eguchi T; Calderwood SK
Subcell Biochem; 2023; 101():141-158. PubMed ID: 36520306
[TBL] [Abstract][Full Text] [Related]
18. p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function.
Grammatikakis N; Lin JH; Grammatikakis A; Tsichlis PN; Cochran BH
Mol Cell Biol; 1999 Mar; 19(3):1661-72. PubMed ID: 10022854
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of the kinase DYRK1A by targeting its folding process.
Kii I; Sumida Y; Goto T; Sonamoto R; Okuno Y; Yoshida S; Kato-Sumida T; Koike Y; Abe M; Nonaka Y; Ikura T; Ito N; Shibuya H; Hosoya T; Hagiwara M
Nat Commun; 2016 Apr; 7():11391. PubMed ID: 27102360
[TBL] [Abstract][Full Text] [Related]
20. A positive feedback loop between protein kinase CKII and Cdc37 promotes the activity of multiple protein kinases.
Bandhakavi S; McCann RO; Hanna DE; Glover CV
J Biol Chem; 2003 Jan; 278(5):2829-36. PubMed ID: 12435747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
